Table 2.
Symptom profiles of esophagogastroduodenoscopy-assisted/conventional-polyethylene glycol subjects1
| Symptom | None | Mild | Moderate | Severe | Intolerable | P value |
| Bloating | 26/21 | 8/9 | 3/1 | 1/2 | 0/0 | 0.83252 |
| Dizzy | 37/30 | 1/4 | 0/0 | 0/0 | 0/0 | 0.12802 |
| Nausea | 30/18 | 7/10 | 0/6 | 0/1 | 1/0 | 0.00502 |
| Vomiting | 35/30 | 2/2 | 0/1 | 0/1 | 0/0 | 0.33592 |
| Pain | 28/21 | 8/12 | 1/1 | 1/0 | 0/0 | 0.27882 |
| Poor sleep | 22/13 | 9/8 | 11/9 | 0/3 | 0/1 | 0.19152 |
| Taste | 8/4 | 27/20 | 2/9 | 1/2 | 0/0 | 0.01762 |
| Complete | Yes 35/29 | No 3/6 | - | - | - | 0.29633 |
| Other prep | Yes 10/21 | No 28/14 | - | - | - | 0.00473 |
| Refuse | Yes 1/5 | No 37/30 | - | - | - | 0.09823 |
1Values in each cell denote number of esophagogastroduodenoscopy-assisted/conventional-polyethylene glycol subjects; small numbers of subjects in certain categories were pooled as necessary to satisfy criteria for statistical analysis;
2
χ2 test for trend;
3
Fisher’s exact test; bolded P values denote statistical significance.